欧州の結腸直腸がん診断市場は、ドイツ、英国、フランス、イタリア、スペイン、およびその他の欧州諸国に分割されています。ドイツでは、がん分野の発展の加速とがんの有病率の増加により、結腸直腸がん診断市場は今後数年間で成長すると予想されています。連邦保健省の国家がん計画 (Nationaler Krebsplan des Bundesministeriums für Gesundheit) は、がんの検出と品質保証に関する臨床がん登録法 (Gesetz zur Weiterentwicklung der Krebsfrüherkennung und zur Qualitä) を制定する法律への道を開きました。この法律は、組織的で質が保証された結腸がん検診プログラムの実施を規定しています。さらに、この国の結腸直腸がんのスクリーニングアプローチでは、男性と女性の両方に、50歳から54歳までに年に1回少なくとも5回の便免疫化学検査(FIT)を実施し、その後、すべてのFITが陰性だった場合に備えて、55歳で最初のスクリーニング結腸内視鏡検査を実施することになっている。 。 2019年4月4日、結腸直腸がんリスクの上昇を理由に、50歳の男性と55歳の女性に結腸内視鏡検査を受けることを義務付ける結腸直腸スクリーニングプログラムが国レベルで組織された。連邦合同委員会 (G-BA) は、組織化されたがん検診プログラムに関する指令 (oKFE-RL) を採択しました。大腸がん検診はその後初めて実施された組織的事業であり、2019年7月からは50歳以上の被保険者を対象に健康保険会社による定期検診が実施されるようになりました。したがって、結腸直腸がんの有病率の増加と結腸直腸がんスクリーニングに対する政府のアプローチの増加は、欧州の結腸直腸がん診断市場の成長を促進する要因の1つです。
ヨーロッパの結腸直腸がん診断市場は、モダリティに基づいて画像検査と便ベースの検査に二分されます。 2023 年には、画像検査セグメントがヨーロッパの結腸直腸がん診断市場で大きなシェアを獲得しました。画像検査セグメントの市場は、結腸内視鏡検査、CT コロノグラフィー、軟性 S 状結腸鏡検査、カプセル内視鏡検査などにさらに分類されます。便ベースの検査セグメントの市場は、便免疫化学検査 (fit)、グアヤックベースの便潜血検査 (gFOBT)、および便 DNA 検査にサブセグメント化されています。
Europe Colorectal Cancer Diagnostics Strategic Insights
Strategic insights for Europe Colorectal Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Europe Colorectal Cancer Diagnostics Regional Insights
The regional scope of Europe Colorectal Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - Europe Colorectal Cancer Diagnostics Market
Bruker Corp
Eiken Chemical Co., Ltd.
Epigenomics AG
F. Hoffmann-La Roche Ltd
Illumina Inc
Medtronic Plc
Novigenix SA
Quest Diagnostics Inc
Siemens Healthineers AG
Frequently Asked Questions
How big is the Europe Colorectal Cancer Diagnostics Market?
The Europe Colorectal Cancer Diagnostics Market is valued at US$ 3,145.81 Million in 2023, it is projected to reach US$ 4,703.52 Million by 2028.
What is the CAGR for Europe Colorectal Cancer Diagnostics Market by (2023 - 2028)?
As per our report Europe Colorectal Cancer Diagnostics Market, the market size is valued at US$ 3,145.81 Million in 2023, projecting it to reach US$ 4,703.52 Million by 2028. This translates to a CAGR of approximately 8.4% during the forecast period.
What segments are covered in this report?
The Europe Colorectal Cancer Diagnostics Market report typically cover these key segments-
検査法 (画像検査, 便検査)
エンドユーザー (病院, 診断研究所, がん研究機関)
What is the historic period, base year, and forecast period taken for Europe Colorectal Cancer Diagnostics Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Colorectal Cancer Diagnostics Market report:
Historic Period : 2021-2022
Base Year : 2023
Forecast Period : 2024-2028
Who are the major players in Europe Colorectal Cancer Diagnostics Market?
The Europe Colorectal Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Bruker Corp
Eiken Chemical Co., Ltd.
Epigenomics AG
F. Hoffmann-La Roche Ltd
Illumina Inc
Medtronic Plc
Novigenix SA
Quest Diagnostics Inc
Siemens Healthineers AG
Who should buy this report?
The Europe Colorectal Cancer Diagnostics Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Europe Colorectal Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For Europe Colorectal Cancer Diagnostics Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines